Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres

Positron Emission Tomography (PET) imaging has become a prominent tool to capture the spatiotemporal distribution of neurotransmitters and receptors in the brain. The outcome of a PET study can, however, potentially be obscured by suboptimal and/or inconsistent choices made in complex processing pipelines required to reach a quantitative estimate of radioligand binding. Variations in subject selection, experimental design, data acquisition, preprocessing, and statistical analysis may lead to different outcomes and neurobiological interpretations. We here review the approaches used in 105 original research articles published by 21 different PET centres, using the tracer [11C]DASB for quantification of cerebral serotonin transporter binding, as an exemplary case. We highlight and quantify the impact of the remarkable variety of ways in which researchers are currently conducting their studies, while implicitly expecting generalizable results across research groups. Our review provides evidence that the foundation for a given choice of a preprocessing pipeline seems to be an overlooked aspect in modern PET neuroscience. Furthermore, we believe that a thorough testing of pipeline performance is necessary to produce reproducible research outcomes, avoiding biased results and allowing for better understanding of human brain function.

[1]  L. Keltikangas-Järvinen,et al.  Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females , 2017, The international journal of neuropsychopharmacology.

[2]  G. Kranz,et al.  Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression , 2017, Front. Hum. Neurosci..

[3]  G. Kranz,et al.  Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET , 2017, Human brain mapping.

[4]  C. Svarer,et al.  BDNF val66met association with serotonin transporter binding in healthy humans , 2017, Translational Psychiatry.

[5]  D. Greve,et al.  Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  S. Houle,et al.  Serotonin transporter binding is reduced in seasonal affective disorder following light therapy , 2016, Acta psychiatrica Scandinavica.

[7]  J. Luthardt,et al.  Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non‐obese individuals , 2016, The European journal of neuroscience.

[8]  Ciprian Catana,et al.  Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging , 2016, NeuroImage.

[9]  P. Piccini,et al.  Serotonin-to-dopamine transporter ratios in Parkinson disease , 2016, Neurology.

[10]  R. Parsey,et al.  Positron emission tomography quantification of serotonin transporter binding in medication‐free bipolar disorder , 2016, Synapse.

[11]  Claus Svarer,et al.  Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study , 2015, Biological Psychiatry.

[12]  F. Turkheimer,et al.  Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study , 2015, Psychological Medicine.

[13]  Jae Sung Lee,et al.  Putaminal serotonergic innervation , 2015, Neurology.

[14]  Claus Svarer,et al.  Functional connectivity of the dorsal and median raphe nuclei at rest , 2015, NeuroImage.

[15]  Jean-Dominique Gallezot,et al.  Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake. , 2015, Nuclear medicine and biology.

[16]  Jeong-Hee Kim,et al.  Serotonin transporter availability in thalamic subregions in schizophrenia: A study using 7.0-T MRI with [11C]DASB high-resolution PET , 2015, Psychiatry Research: Neuroimaging.

[17]  L. Siever,et al.  Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB. , 2014, Journal of psychiatric research.

[18]  R. Parsey,et al.  Quantifying serotonin transporters by PET with [11C]‐DASB before and after interferon‐α treatment , 2014, Synapse.

[19]  C. Svarer,et al.  In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users. , 2014, The international journal of neuropsychopharmacology.

[20]  Y. Okubo,et al.  Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB. , 2014, The international journal of neuropsychopharmacology.

[21]  F. Turkheimer,et al.  Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. , 2014, The Journal of clinical investigation.

[22]  Hidehiko Takahashi,et al.  Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2). , 2013, The international journal of neuropsychopharmacology.

[23]  Brian A. Nosek,et al.  Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.

[24]  P. M. Rasmussen,et al.  Prefrontal serotonin transporter availability is positively associated with the cortisol awakening response , 2013, European Neuropsychopharmacology.

[25]  Rasmus R. Paulsen,et al.  List-Mode PET Motion Correction Using Markerless Head Tracking: Proof-of-Concept With Scans of Human Subject , 2013, IEEE Transactions on Medical Imaging.

[26]  Peter S. Talbot,et al.  Pre- and Postsynaptic Serotonergic Differences in Males with Extreme Levels of Impulsive Aggression Without Callous Unemotional Traits: A Positron Emission Tomography Study Using 11C-DASB and 11C-MDL100907 , 2012, Biological Psychiatry.

[27]  I. Buvat,et al.  A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology , 2012, Physics in medicine and biology.

[28]  Siegfried Kasper,et al.  Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas , 2012, NeuroImage.

[29]  Siegfried Kasper,et al.  Normative database of the serotonergic system in healthy subjects using multi-tracer PET , 2012, NeuroImage.

[30]  A. Björklund,et al.  Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson’s Patients Treated with Dopamine Grafts , 2012, Science Translational Medicine.

[31]  L. Marner,et al.  Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study , 2012, Neurobiology of Aging.

[32]  Swen Hesse,et al.  Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Julie C Price,et al.  Age, Sex, and Reproductive Hormone Effects on Brain Serotonin-1A and Serotonin-2A Receptor Binding in a Healthy Population , 2011, Neuropsychopharmacology.

[34]  J. Steele,et al.  A non- synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: Results of a genome-wide association study , 2010, Molecular Psychiatry.

[35]  Marc Laruelle,et al.  Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain , 2010, NeuroImage.

[36]  Masanori Ichise,et al.  Reduced serotonin transporter binding in the insular cortex in patients with obsessive–compulsive disorder: A [11C]DASB PET study , 2010, NeuroImage.

[37]  Yasuomi Ouchi,et al.  Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease , 2009, Journal of Nuclear Medicine.

[38]  Claus Svarer,et al.  High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding , 2009, NeuroImage.

[39]  Ronald Boellaard,et al.  HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest Study , 2009, Journal of Nuclear Medicine.

[40]  Alan A. Wilson,et al.  Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB , 2008, Movement disorders : official journal of the Movement Disorder Society.

[41]  P. Cowen,et al.  Effects of Citalopram Infusion on the Serotonin Transporter Binding of [11C]DASB in Healthy Controls , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  Russell A. Poldrack,et al.  Guidelines for reporting an fMRI study , 2008, NeuroImage.

[43]  Christer Halldin,et al.  Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET , 2008, NeuroImage.

[44]  P. Cowen,et al.  5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB. , 2007, The American journal of psychiatry.

[45]  Masanori Ichise,et al.  Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]DASB; Comparison with Bipolar Disorder , 2007, Biological Psychiatry.

[46]  R. Parsey,et al.  In vivo Quantification of Serotonin Transporters Using [11C]DASB and Positron Emission Tomography in Humans: Modeling Considerations , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  Mark Slifstein,et al.  Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  Ramin V. Parsey,et al.  Acute Occupancy of Brain Serotonin Transporter by Sertraline as Measured by [11C]DASB and Positron Emission Tomography , 2006, Biological Psychiatry.

[49]  Katsuyuki Tanimoto,et al.  Effects of image reconstruction algorithm on neurotransmission PET studies in humans: Comparison between filtered backprojection and ordered subsets expectation maximization , 2006, Annals of nuclear medicine.

[50]  S. Tanada,et al.  A dose-finding study of duloxetine based on serotonin transporter occupancy , 2006, Psychopharmacology.

[51]  Masanori Ichise,et al.  PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  Zsolt Szabo,et al.  Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB , 2005, Neuropsychopharmacology.

[53]  Sylvain Houle,et al.  Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? , 2005, Nuclear medicine and biology.

[54]  D. Lee,et al.  Performance evaluation of SIEMENS CTI ECAT EXACT 47 PET scanner USING NEMA NU2-2001 , 2004, IEEE Symposium Conference Record Nuclear Science 2004..

[55]  Mark Slifstein,et al.  Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[56]  J. John Mann,et al.  OS-EM and FBP reconstructions at low count rates: effect on 3D PET studies of [11C] WAY-100635 , 2004, NeuroImage.

[57]  Jeih-San Liow,et al.  Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).

[58]  Jeih-San Liow,et al.  Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  Ronald Boellaard,et al.  Attenuation correction of PET activation studies in the presenceof task-related motion , 2003, NeuroImage.

[60]  Richard E Carson,et al.  Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  Paul Kinahan,et al.  NEMA NU2-2001 performance results for the GE advance PET system , 2002, 2002 IEEE Nuclear Science Symposium Conference Record.

[62]  N. Sato,et al.  A new high resolution PET scanner dedicated to brain research , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[63]  Alan A. Wilson,et al.  Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  R. Boellaard,et al.  Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[65]  W. Heiss,et al.  The ECAT HRRT: performance and first clinical application of the new high resolution research tomograph , 2000, 2000 IEEE Nuclear Science Symposium. Conference Record (Cat. No.00CH37149).

[66]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[68]  W. J. Lorenz,et al.  Performance evaluation of the whole-body PET scanner ECAT EXACT HR + , 1997 .

[69]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[70]  Gunnar Brix,et al.  Performance evaluation of the whole-body PET scanner ECAT EXACT HR/sup +/ , 1996, 1996 IEEE Nuclear Science Symposium. Conference Record.

[71]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  R. Hinz,et al.  Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a PET study using 11C-DASB and 11C-MDL100907. , 2012 .

[73]  M. Patt,et al.  Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter , 2010, Journal of Neurology.

[74]  Keishi Kitamura,et al.  Performance characteristics of a new 3-dimensional continuous-emission and spiral-transmission high-sensitivity and high-resolution PET camera evaluated with the NEMA NU 2-2001 standard. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[75]  S. Holte,et al.  A preliminary evaluation of the scanditronix PC2048-15B brain scanner , 2004, European Journal of Nuclear Medicine.

[76]  S. Houle,et al.  Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.